Daphne Koller: How Machine Learning Is Transforming Drug Discovery

Daphne Koller: How machine learning is transforming drug discovery

Stanford University School of Engineering

Transforming Drug Discovery Using Machine Learning

Machine Learning: New Approach to Drug Discovery - Daphne Koller, Founder, Insitro

Transforming Drug Discovery using Digital Biology Daphne Koller

Machine Learning: A New Approach to Drug Discovery | Daphne Koller | WiDS 2020

Daphne Koller | Machine Learning: A New Approach to Drug Discovery | Stanford 2020

Women in Data Science Worldwide

Daphne Koller: AI-Driven Drug Discovery Using Digital Biology | TransformX 2022

New Horizons in Generative AI: Machine Learning for Translatable Drug Discovery

Daphne Koller: Machine Learning: A New Approach to Drug Discovery

Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332

The TWIML AI Podcast with Sam Charrington

Broad Institute Machine Learning in Drug Discovery Symposium 2023: Keynote - Daphne Koller

Broad Institute

Machine Learning: A new approach to drug discovery

Fields Institute

Machine learning for drug discovery with insitro's Daphne Koller

Weights & Biases

MIDL 2020, Keynote by Daphne Koller: Machine learning: a new approach to drug discovery

Machine learning: A New Approach to Drug Discovery | Daphne Koller | MIDL 2020

DSAI by Dr. Osbert Tay

insitro | Daphne Koller in discussion with Parker Moss | GERS2022

Genomics England

Rethinking Drug Discovery Using Machine Learning

Amazon Web Services

AIMI Symposium 2020 - Keynote & Fireside Chat with Eric Topol and Daphne Koller

AI-First: Daphne Koller’s plan to revolutionize drug discovery

CPP Investments | Investissements RPC

No Priors Ep. 6 | With Daphne Koller from Insitro

No Priors: AI, Machine Learning, Tech, & Startups